Q32 Bio (QTTB) Other financing activities (2018 - 2024)
Q32 Bio's (QTTB) quarterly Other financing activities came in at $317000.0 in Q4 2024, up 317.11% year-on-year from $76000.0 in Q1 2024, and down 68.2% quarter-over-quarter from $997000.0 in Q3 2024.
Q32 Bio (QTTB) Other financing activities (2018 - 2024) Analysis & Trends
Q32 Bio's Other financing activities history runs 7 years deep, the most recent figure standing at $317000.0 for Q4 2024.
- On a quarterly basis, Other financing activities rose 317.11% year-over-year to $317000.0 in Q4 2024; TTM through Dec 2025 was $1.3 million, a 22.43% decrease from a year earlier, with the FY2024 full-year figure at $1.7 million, up 1498.11% from the prior year.
- Other financing activities fell to $317000.0 in Q4 2024 per QTTB's latest filing, from $997000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $51.8 million in Q4 2020 and bottomed at -$438000.0 in Q2 2022.
- The 5-year median for Other financing activities is $139000.0 (2020), against an average of $3.4 million.
- Across the five-year window, Other financing activities plunged 3444.44% in 2021 and jumped 2433.33% in 2024, its largest moves.
- Year by year, Other financing activities stood at $51.8 million in 2020, then slumped by 98.69% to $681000.0 in 2021, then tumbled by 164.32% to -$438000.0 in 2022, then jumped by 117.35% to $76000.0 in 2023, then surged by 317.11% to $317000.0 in 2024.
- Per Business Quant, the three latest QTTB Other financing activities figures stand at $317000.0 (Q4 2024), $997000.0 (Q3 2024), and $380000.0 (Q2 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Q32 Bio | 225.00 Mn | 174.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 317,000.00 |
| Dec 31, 2024 | 317,000.00 |
| Sep 30, 2024 | 997,000.00 |
| Sep 30, 2024 | 997,000.00 |
| Jun 30, 2024 | 380,000.00 |
| Jun 30, 2024 | 380,000.00 |
| Dec 31, 2023 | 76,000.00 |
| Dec 31, 2023 | 76,000.00 |
| Jun 30, 2023 | 15,000.00 |
| Jun 30, 2023 | 15,000.00 |
| Mar 31, 2023 | 15,000.00 |
| Mar 31, 2023 | 15,000.00 |
| Jun 30, 2022 | -438,000.00 |
| Jun 30, 2022 | -438,000.00 |
| Mar 31, 2022 | 439,000.00 |
| Mar 31, 2022 | 439,000.00 |
| Dec 31, 2021 | 681,000.00 |
| Dec 31, 2021 | 681,000.00 |
| Sep 30, 2021 | -301,000.00 |
| Sep 30, 2021 | -301,000.00 |